SCHEMBL32677482

SCHEMBL32677482

COC(=O)c1ccc(C2CCC(N)CC2)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 5/20 0.42
GAA P10253 3/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 3/20 0.42
CASP1 P29466 2/20 0.42
CASP7 P55210 2/20 0.42
ATM Q13315 2/20 0.42
MAPT P10636 2/20 0.42
GLA P06280 1/20 0.42
SLC6A3 Q01959 2/20 0.39
PTGER4 P35408 1/20 0.39
TSHR P16473 2/20 0.38
ABL1 P00519 1/20 0.38
PDK2 Q15119 2/20 0.37
PDK4 Q16654 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1726032 0.93 KDM4E (0.46) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL1779047 0.87 KDM4E (0.42) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL1779046 0.87 KDM4E (0.42) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL13544503 0.87 ACMSD (0.46) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL12488998 0.87 ALDH1A1 (0.43) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL1781399 0.86 KDM4E (0.41) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL1781398 0.86 KDM4E (0.41) ALDH1A1KDM4EGAAHSD17B10HPGD
Hydrochloric Acid SCHEMBL30409796 0.85 ALDH1A1 (0.43) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL20503220 0.85 ACMSD (0.48) ALDH1A1KDM4EGAAHSD17B10HPGD
SCHEMBL26478575 0.85 ACMSD (0.48) ALDH1A1KDM4EGAAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026042018-A1 4-{4-[(1-{[4-(PROPAN-2-YL)PHENYL]CARBAMOYL)-D-PROLYL)AMINO]CYCLOHEXYL}BENZOIC ACID DERIVATIVES AS GIPR ANTAGONISTS FOR THE TREATMENT OF DIABETES PFIZER INC. (US) 2026-02-26 WO disclosed
US-20260055057-A1 GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF PFIZER INC. (US) 2026-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055057-A1 GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF GIPR, GLP1R, GPR119 ALDH1A1 2197/4885KDM4E 4203/4885GAA 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.